Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|April 10, 2018
Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapyShama Khan, Imane Bjij, Robin M Betz, et al.
Journal of Molecular Structure|June 21, 2021
COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, et al.
Molecules (Basel, Switzerland)|August 31, 2019
Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused ModellingImane Bjij, Pritika Ramharack, Shama Khan, et al.
Journal of Cellular Biochemistry|March 12, 2019
Distinguishing the optimal binding mechanism of an E3 ubiquitin ligase: Covalent versus noncovalent inhibitionImane Bjij, Shama Khan, Pritika Ramharak, et al.
The Protein Journal|September 21, 2018
Exploring the Structural Mechanism of Covalently Bound E3 Ubiquitin Ligase: Catalytic or Allosteric Inhibition?Imane Bjij, Shama Khan, Robin Betz, et al.
Pharmaceuticals (Basel, Switzerland)|July 18, 2018
In Silico SAR Studies of HIV-1 InhibitorsIsmail Hdoufane, Imane Bjij, Mahmoud Soliman, et al.
Expert Opinion on Drug Discovery|September 13, 2018
An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapyFisayo Olotu, Emmanuel Adeniji, Clement Agoni, et al.
Future Medicinal Chemistry|October 2, 2018
Covalent simulations of covalent/irreversible enzyme inhibition in drug discovery: a reliable technical protocolShama Khan, Imane Bjij, Fisayo A Olotu, et al.
Pageof 2